These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9457047)

  • 1. Alternative modes of substrate distortion in enzyme and antibody catalyzed ferrochelation reactions.
    Blackwood ME; Rush TS; Romesberg F; Schultz PG; Spiro TG
    Biochemistry; 1998 Jan; 37(3):779-82. PubMed ID: 9457047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyrin distortion from resonance Raman intensities of out-of-plane modes: Computation and modeling of N-methylmesoporphyrin, a ferrochelatase transition state analog.
    Jarzecki AA; Spiro TG
    J Phys Chem A; 2005 Jan; 109(3):421-30. PubMed ID: 16833362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallation of the transition-state inhibitor N-methyl mesoporphyrin by ferrochelatase: implications for the catalytic reaction mechanism.
    Shipovskov S; Karlberg T; Fodje M; Hansson MD; Ferreira GC; Hansson M; Reimann CT; Al-Karadaghi S
    J Mol Biol; 2005 Oct; 352(5):1081-90. PubMed ID: 16140324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porphyrin distortion during affinity maturation of a ferrochelatase antibody, monitored by Resonance Raman spectroscopy.
    Venkateshrao S; Yin J; Jarzecki AA; Schultz PG; Spiro TG
    J Am Chem Soc; 2004 Dec; 126(50):16361-7. PubMed ID: 15600337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conserved active-site loop residues of ferrochelatase induce porphyrin conformational changes necessary for catalysis.
    Shi Z; Franco R; Haddad R; Shelnutt JA; Ferreira GC
    Biochemistry; 2006 Mar; 45(9):2904-12. PubMed ID: 16503645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and mechanistic basis of porphyrin metallation by ferrochelatase.
    Lecerof D; Fodje M; Hansson A; Hansson M; Al-Karadaghi S
    J Mol Biol; 2000 Mar; 297(1):221-32. PubMed ID: 10704318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-catalyzed porphyrin metallation.
    Cochran AG; Schultz PG
    Science; 1990 Aug; 249(4970):781-3. PubMed ID: 2389144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissection of porphyrin-induced conformational dynamics in the heme biosynthesis enzyme ferrochelatase.
    Asuru AP; An M; Busenlehner LS
    Biochemistry; 2012 Sep; 51(36):7116-27. PubMed ID: 22897320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of protoporphyrin IX and metal derivatives to the active site of wild-type mouse ferrochelatase at low porphyrin-to-protein ratios.
    Lu Y; Sousa A; Franco R; Mangravita A; Ferreira GC; Moura I; Shelnutt JA
    Biochemistry; 2002 Jul; 41(26):8253-62. PubMed ID: 12081474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphyrin binding and distortion and substrate specificity in the ferrochelatase reaction: the role of active site residues.
    Karlberg T; Hansson MD; Yengo RK; Johansson R; Thorvaldsen HO; Ferreira GC; Hansson M; Al-Karadaghi S
    J Mol Biol; 2008 May; 378(5):1074-83. PubMed ID: 18423489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyrin interactions with wild-type and mutant mouse ferrochelatase.
    Franco R; Ma JG; Lu Y; Ferreira GC; Shelnutt JA
    Biochemistry; 2000 Mar; 39(10):2517-29. PubMed ID: 10704201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of porphyrin distortions for the ferrochelatase reaction.
    Sigfridsson E; Ryde U
    J Biol Inorg Chem; 2003 Feb; 8(3):273-82. PubMed ID: 12589563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and kinetic evidence for strain in biological catalysis.
    Romesberg FE; Santarsiero BD; Spiller B; Yin J; Barnes D; Schultz PG; Stevens RC
    Biochemistry; 1998 Oct; 37(41):14404-9. PubMed ID: 9772166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nickel(II) chelatase variants directly evolved from murine ferrochelatase: porphyrin distortion and kinetic mechanism.
    McIntyre NR; Franco R; Shelnutt JA; Ferreira GC
    Biochemistry; 2011 Mar; 50(9):1535-44. PubMed ID: 21222436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific orientation of porphyrin at the binding site of catalytic antibody.
    Kawamura-Konishi Y; Neya S; Funasaki N; Suzuki H
    Biochem Biophys Res Commun; 1996 Aug; 225(2):537-44. PubMed ID: 8753797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward an efficient DNAzyme.
    Li Y; Sen D
    Biochemistry; 1997 May; 36(18):5589-99. PubMed ID: 9154943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal ion selectivity and substrate inhibition in the metal ion chelation catalyzed by human ferrochelatase.
    Davidson RE; Chesters CJ; Reid JD
    J Biol Chem; 2009 Dec; 284(49):33795-9. PubMed ID: 19767646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resonance Raman Spectroscopic Examination of Ferrochelatase-induced Porphyrin Distortion.
    Franco R; Al-Karadaghi S; Ferreira GC
    J Porphyr Phthalocyanines; 2011 May; 15(5):357-363. PubMed ID: 21776189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate interactions with human ferrochelatase.
    Medlock A; Swartz L; Dailey TA; Dailey HA; Lanzilotta WN
    Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1789-93. PubMed ID: 17261801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme synthase (ferrochelatase) catalyzes the removal of iron from heme and demetalation of metalloporphyrins.
    Taketani S; Ishigaki M; Mizutani A; Uebayashi M; Numata M; Ohgari Y; Kitajima S
    Biochemistry; 2007 Dec; 46(51):15054-61. PubMed ID: 18044970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.